Bausch + Lomb Corporation (BLCO) Key Metrics
BLCO valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $5.89B
- Enterprise value
- $10.87B
- P/E (TTM)
- —
- Forward P/E
- 11.4
- PEG ratio
- 0.89
- Price / sales
- 1.1 10-yr median 1.4
- Price / book
- 1.0 10-yr median 0.9
- EV / EBITDA
- 14.8 10-yr median 19.4
- Dividend yield
- —
- Beta
- 0.56
BLCO key metrics, 2018–2025
Fiscal year ended December 31, 2025 · U.S. dollarsBLCO valuation Price multiples at each fiscal year-end price.
BLCO returns How much profit the business earns on the capital it uses.
BLCO per-share figures Results divided by the shares outstanding at year-end.
BLCO financial health Debt, liquidity and how easily interest is covered.
BLCO efficiency & capital use Working capital cycle and where the cash goes.
BLCO valuation history
BLCO returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BLCO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BLCO cash returned to shareholders
BLCO price vs earnings per share
BLCO key metrics
2018–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $6.04B | $6.35B | $5.98B | $5.43B | — | — | — | — |
| Enterprise value | $11.03B | $10.98B | $10.32B | $7.60B | — | — | — | — |
| P/E ratio | — | — | — | 904.8 | — | — | — | — |
| Price / sales | 1.2 | 1.3 | 1.4 | 1.4 | — | — | — | — |
| Price / book | 0.9 | 1.0 | 0.9 | 0.8 | — | — | — | — |
| Price / free cash flow | — | — | — | 31.9 | — | — | — | — |
| Price / operating cash flow | 21.4 | 27.4 | — | 15.7 | — | — | — | — |
| EV / sales | 2.2 | 2.3 | 2.5 | 2.0 | — | — | — | — |
| EV / EBITDA | 20.6 | 18.3 | 20.7 | 12.7 | — | — | — | — |
| EV / free cash flow | — | — | — | 44.7 | — | — | — | — |
| Earnings yield | −6.0% | −5.0% | −4.3% | 0.1% | — | — | — | — |
| Free cash flow yield | −1.1% | −0.9% | −3.3% | 3.1% | — | — | — | — |
| Shareholder yield (dividends + buybacks) | — | 0.2% | 0.2% | 0.2% | — | — | — | — |
| Share price at fiscal year-end | $17.08 | $18.06 | $17.06 | $15.51 | — | — | — | — |
| Per share | ||||||||
| Revenue per share | $14.42 | $13.62 | $11.83 | $10.77 | $10.76 | $9.75 | $10.79 | $10.47 |
| Earnings per share | −$1.02 | −$0.90 | −$0.74 | $0.02 | $0.52 | −$0.05 | $0.85 | $2.03 |
| Operating cash flow per share | $0.80 | $0.66 | −$0.05 | $0.99 | $2.49 | $1.49 | $2.28 | $2.18 |
| Free cash flow per share | −$0.19 | −$0.17 | −$0.56 | $0.49 | $1.94 | $0.75 | $1.77 | $1.89 |
| Cash per share | $1.08 | $0.87 | $0.95 | $1.09 | $0.50 | $0.68 | $0.55 | — |
| Book value per share | $18.22 | $18.40 | $19.54 | $20.09 | $26.65 | $28.34 | $28.45 | — |
| Tangible book value per share | −$4.50 | −$4.39 | −$3.75 | $1.34 | $7.08 | $7.63 | $7.29 | — |
| Capex per share | $0.99 | $0.83 | $0.52 | $0.50 | $0.55 | $0.74 | $0.51 | $0.29 |
| Debt per share | $15.18 | $14.03 | $13.34 | $7.30 | $0.40 | $0.29 | $0.27 | — |
| Shares outstanding | 353.8M | 351.8M | 350.5M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M |
| Change in shares outstanding | +0.6% | +0.4% | +0.1% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | −5.6% | −4.8% | −3.7% | 0.1% | 1.9% | −0.2% | 3.0% | — |
| Return on invested capital (ROIC) | 1.3% | 1.1% | 1.0% | 1.1% | 2.1% | 1.3% | 3.0% | — |
| Return on assets (ROA) | −2.6% | −2.4% | −2.1% | 0.1% | 1.6% | −0.2% | 2.6% | — |
| Return on tangible assets | −6.0% | −5.8% | −4.9% | 0.1% | 4.6% | −0.4% | 7.3% | — |
| Free cash flow margin | −1.3% | −1.2% | −4.8% | 4.5% | 18.1% | 7.7% | 16.4% | 18.1% |
| Income quality (OCF / net income) | — | — | — | 57.50 | 4.80 | — | 2.68 | 1.07 |
| Financial health | ||||||||
| Total debt | $5.37B | $4.94B | $4.68B | $2.55B | $140.0M | $101.0M | $93.0M | — |
| Cash & short-term investments | $383.0M | $305.0M | $334.0M | $380.0M | $174.0M | $238.0M | $192.0M | — |
| Net debt | $4.99B | $4.63B | $4.34B | $2.17B | −$34.0M | −$137.0M | −$99.0M | — |
| Debt / equity | 0.83 | 0.76 | 0.68 | 0.36 | 0.02 | 0.01 | 0.01 | — |
| Debt / assets | 0.38 | 0.37 | 0.35 | 0.23 | 0.01 | 0.01 | 0.01 | — |
| Net debt / EBITDA | 9.32 | 7.71 | 8.70 | 3.64 | −0.05 | −0.19 | −0.11 | — |
| Current ratio | 1.55 | 1.60 | 1.74 | 1.65 | 1.49 | 1.82 | 1.64 | — |
| Quick ratio | 1.04 | 1.01 | 1.09 | 1.16 | 0.97 | 1.14 | 1.07 | — |
| Interest coverage | 0.4 | 0.4 | 0.5 | 1.4 | 5.2 | 13.7 | 2.9 | 52.0 |
| Working capital | $1.06B | $1.05B | $1.16B | $841.0M | $536.0M | $745.0M | $660.0M | — |
| Invested capital | $11.44B | $11.10B | $11.19B | $9.21B | $9.29B | $9.78B | $9.86B | — |
| Tangible asset value | −$1.52B | −$1.47B | −$1.24B | $536.0M | $2.55B | $2.74B | $2.62B | — |
| Net current asset value | −$4.53B | −$4.14B | −$3.78B | −$1.91B | $214.0M | $376.0M | $259.0M | — |
| Graham number | — | — | — | $2.78 | $17.66 | — | $23.35 | — |
| Graham net-net per share | −$16.16 | −$15.16 | −$14.32 | −$8.01 | −$1.20 | −$0.71 | −$1.18 | — |
| Capital allocation | ||||||||
| Share buybacks (net) | — | $12.0M | $10.0M | $11.0M | — | — | — | — |
| Dividends + buybacks / free cash flow | — | — | — | 6.5% | — | — | — | — |
| Capex / revenue | 6.8% | 6.1% | 4.4% | 4.6% | 5.1% | 7.6% | 4.8% | 2.8% |
| Capex / operating cash flow | 123.3% | 125.4% | — | 50.7% | 22.1% | 49.6% | 22.5% | 13.2% |
| Capex / depreciation | 0.83 | 0.67 | 0.47 | 0.46 | 0.47 | 0.59 | 0.38 | 0.20 |
| Stock-based compensation / revenue | 2.9% | 1.9% | 1.8% | 1.6% | 1.6% | 1.5% | 1.3% | 1.2% |
| R&D / revenue | 7.3% | 7.2% | 7.8% | 8.1% | 7.2% | 8.2% | 6.8% | 6.0% |
| SG&A / revenue | 43.8% | 43.5% | 41.9% | 39.2% | 36.9% | 36.7% | 36.6% | 36.2% |
| Efficiency | ||||||||
| Days sales outstanding | 80.4 | 72.4 | 70.5 | 70.1 | 66.2 | 72.6 | 68.9 | — |
| Days of inventory on hand | 159.1 | 201.2 | 184.1 | 144.2 | 147.8 | 171.6 | 162.8 | — |
| Days payables outstanding | 61.4 | 88.8 | 93.3 | 66.8 | 51.9 | 62.5 | 72.1 | — |
| Cash conversion cycle (days) | 178.0 | 184.8 | 161.3 | 147.5 | 162.1 | 181.7 | 159.7 | — |
| Receivables turnover | 4.54 | 5.04 | 5.18 | 5.21 | 5.51 | 5.03 | 5.30 | — |
| Payables turnover | 5.94 | 4.11 | 3.91 | 5.46 | 7.04 | 5.84 | 5.06 | — |
| Inventory turnover | 2.29 | 1.81 | 1.98 | 2.53 | 2.47 | 2.13 | 2.24 | — |
| Asset turnover | 0.37 | 0.36 | 0.34 | 0.34 | 0.34 | 0.30 | 0.33 | — |
| Average receivables | $1.12B | $950.5M | $800.5M | $723.5M | $683.0M | $679.0M | $713.0M | — |
| Average payables | $388.5M | $455.5M | $419.5M | $278.0M | $208.5M | $220.0M | $262.0M | — |
| Average inventory | $1.01B | $1.03B | $828.0M | $600.0M | $594.0M | $604.0M | $592.0M | — |
| Intangibles / total assets | 57.3% | 59.5% | 60.7% | 58.9% | 63.3% | 64.3% | 64.6% | — |
Computed from BLCO's annual financial statements (latest annual report filed February 18, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BLCO valuation and financial ratios
Bausch + Lomb earned a return on equity of −5.6% and a return on invested capital of 1.3% in fiscal 2025. It ended the year with $5.4 billion of debt and $383.0 million in cash and short-term investments, net debt of $5.0 billion.
See the BLCO income statement, the BLCO chart for price history, or the BLCO stock overview for the latest quote and news.
BLCO key metrics FAQ
What is Bausch + Lomb's EV/EBITDA?
Bausch + Lomb's enterprise value was 20.6 times EBITDA at the end of fiscal 2025 (enterprise value $11.0 billion, EBITDA $535.0 million); the current EV/EBITDA is 14.8.
What is Bausch + Lomb's return on equity?
Bausch + Lomb's return on equity (ROE) was −5.6% in fiscal 2025: net income of -$360.0 million on average shareholders' equity of $6.5 billion.
What is Bausch + Lomb's ROIC?
Bausch + Lomb's return on invested capital was 1.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Bausch + Lomb have?
Bausch + Lomb had total debt of $5.4 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.83 and $5.0 billion of net debt (9.32 times EBITDA).
What is Bausch + Lomb's free cash flow yield?
Bausch + Lomb generated -$66.0 million of free cash flow in fiscal 2025, a free cash flow yield of −1.1% on its market value at year-end ($6.0 billion).
What is Bausch + Lomb's current ratio?
Bausch + Lomb's current ratio was 1.55 at the end of fiscal 2025: current assets were 1.55 times current liabilities.